Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Jesper Eykens Søgaard ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   5.9% 5.0% 3.1% 4.6% 4.4% 4.2% 6.1% 6.1%   Credit score (0-100)   41 45 56 44 47 47 38 38   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -240 -267 -263 -357 -209 -215 0.0 0.0   EBITDA   -818 -963 -835 -1,033 -964 -749 0.0 0.0   EBIT   -884 -1,057 -931 -1,159 -1,123 -905 0.0 0.0   Pre-tax profit (PTP)   107.7 83.3 318.4 -22.8 112.8 492.8 0.0 0.0   Net earnings   82.3 63.5 248.0 -18.6 87.5 383.9 0.0 0.0   Pre-tax profit without non-rec. items   108 83.3 318 -22.8 113 493 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   179 165 131 432 334 238 0.0 0.0   Shareholders equity total   658 613 751 619 592 858 508 508   Interest-bearing liabilities   770 569 462 662 737 350 337 337   Balance sheet total (assets)   3,527 2,325 2,164 1,716 1,604 2,169 845 845   Net Debt   770 569 462 662 737 350 337 337     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -240 -267 -263 -357 -209 -215 0.0 0.0   Gross profit growth   1.5% -10.9% 1.4% -36.0% 41.5% -2.8% 0.0% 0.0%   Employees   1 1 1 2 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 100.0% 0.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,527 2,325 2,164 1,716 1,604 2,169 845 845   Balance sheet change%   80.1% -34.1% -6.9% -20.7% -6.5% 35.3% -61.0% 0.0%   Added value   -818.2 -962.7 -835.4 -1,033.0 -996.6 -748.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   435 -169 -191 114 -318 -313 -238 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 -4.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   367.5% 396.2% 354.0% 324.4% 537.5% 421.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.4% 5.7% 19.1% 2.7% 10.2% 32.1% 0.0% 0.0%   ROI %   19.3% 12.5% 34.4% 4.1% 12.4% 45.4% 0.0% 0.0%   ROE %   18.3% 10.0% 36.4% -2.7% 14.4% 52.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.6% 26.4% 34.7% 36.1% 36.9% 39.6% 60.1% 60.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -94.1% -59.1% -55.3% -64.1% -76.5% -46.7% 0.0% 0.0%   Gearing %   117.0% 92.7% 61.6% 106.9% 124.5% 40.8% 66.3% 66.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   17.1% 12.7% 21.4% 13.5% 8.0% 20.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.6 0.7 0.3 0.0 0.0 0.0 0.0   Current Ratio   0.8 0.6 0.7 0.3 0.0 0.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -643.9 -611.9 -369.8 -746.3 -939.6 -1,249.4 -168.5 -168.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -818 -963 -835 -517 -498 -749 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -818 -963 -835 -517 -482 -749 0 0   EBIT / employee   -884 -1,057 -931 -580 -562 -905 0 0   Net earnings / employee   82 64 248 -9 44 384 0 0